Advances in breast imaging: A dilemma or progress?

Recent Results in Cancer Research

Volumn 173, Issue , 2009, Pages 159-181

  Helbich, Thomas H ^a   Flöry, Daniel ^b   Fuchsjaeger, Michael W ^b   Weisman, Christian F ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN TUMOR; BREAST CANCER; BREAST DISEASE; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ECHOMAMMOGRAPHY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW;

BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; ELECTRIC IMPEDANCE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY; ULTRASONOGRAPHY, MAMMARY;

EID: 77953672819     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-31611-4_10     Document Type: Review

References (41)

1. American College of Radiology (2003) Illustrated breast imaging reporting and data system (BI-RADS): ultrasound, 1st edn. American College of Radiology, Reston, VA
2. Bremer C, Ntziachristos V, Weitkamp B, Theilmeier G, Heindel W, Weissleder R (2005) Optical imaging of spontaneous breast tumors using protease sensing 'smart' optical probes. Invest Radiol 40:321-327
3. Buchberger W, Niehoff A, Obrist P, DeKoekkoek- Doll P, Dunser M (2000) Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography. Semin Ultrasound CT MR 21(4):325-336
4. Daldrup-Link HE, Brasch RC (2003) Macromolecular contrast agents for MR mammography: current status. Eur Radiol 13:354-365
5. Daldrup-Link HE, Rydland J, Helbich TH et al. (2003) Quantification of breast tumor microvascular permeability with feruglose-enhanced MR imaging: initial phase II multicenter trial. Radiology 229:885-892
6. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW (1998) Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 338:1089-1096
7. Floery D, Helbich TH, Riedl CC et al. (2005) Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience. Invest Radiol 328-335
8. Fricke H, Morse S (1926) The electric capacity of tumors in the breast. J Cancer Res 16:340-376
9. Fuchsjäger MH, Helbich TH, Ringl H et al. (2002) Electrical impedance scanning in the differentiation of suspicious breast lesions: comparison with mammography, ultrasound and histopathology. Fortschr Röntgenstr 174:1522-1529
10. Fuchsjäger M, Diebold T, Szabo B, Malich A, Vogl T, Helbich T (2003) Electrical impedance scanning European multicenter evaluation: final definition of adjunctive value to mammography and sonography for differentiation of malignant and benign breast lesions. Radiology 229:513
11. Fuchsjäger MH, Flory D, Reiner CS, Rudas M, Riedl CC, Helbich TH (2005) The negative predictive value of electrical impedance scanning in BI-RADS category IV breast lesions. Invest Radiol 40:478-485
12. Funovics MA, Kapeller B, Hoeller C et al. (2004) MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents. Magn Reson Imaging 22:843-850
13. Helbich TH (2000) Contrast-enhanced magnetic resonance imaging of the breast. Eur J Radiol 34:208-219
14. Heywang-Köbrunner SH, Schreer I (2003) Bildgebende Mammadiagnostik, 2nd ed. Thieme, New York
15. Hogemann-Savellano D, Bos E, Blondet C et al. (2003) The transferrin receptor: A potential molecular imaging marker for human cancer. Neoplasia 5:495-506
16. Jossinet J (1996) Variability of impeditivity in normal and pathological breast tissue. Med Biol Eng Comput 34:346-350
17. Jossinet J (1998) The impeditivity of freshly excised human breast tissue. Physiol Meas 19:61-75
18. Ke S, Wen X, Gurfinkel M et al. (2003) Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 63:7870-7875
19. Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination and breast US and evaluation of factors that influence them: An analysis of 27,825 patient evaluations. Radiology 225:165-175
20. Kuhl CK, Jost P, Morakkabati N, Zivanovic O, Schild HH, Gieseke J (2006) Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology 239: 666-676
21. Kumar R, Alavi A (2004) Fluorodeoxyglucose-PET in the management of breast cancer. Radiol Clin N Am 42:1113-1122, ix
22. Leconte I, Feger C, Galant C, Berliere M, Vande Berg B, D'Hoore W, Maldague B (2003) Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: The importance of radiologic breast density. AJR Am J Roentgenol 180:1675-1679
23. Linden HM, Stekhova SA, Link JM et al. (2006) Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J Clin Oncol 24:2793-2799
24. Madjar H, Ohlinger R, Mundinger A, Watermann D, Frenz JP, Bader W, Schulz-Wendtland R, Degenhardt F (2006) BI-RADS-analogue DEGUM criteria for findings in breast ultrasound - consensus of the DEGUM committee on breast ultrasound Ultraschall Med 27:374-379
25. Malich A, Böhm T, Facius M et al. (2001) Additional value of electrical impedance scanning: experience of 240 histologically-proven breast lesions. Eur J Cancer 37:2324-2330
26. Moon WK, Chang RF, Chen CJ, Chen DR, Chen WL (2005) Solid breast masses: classification with computer-aided analysis of continuous US images obtained with probe compression. Radiology 236:458-464
27. Ntziachristos V, Yodh AG, Schnall M, Chance B (2000) Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A 97:2767-2772
28. Perlet C, Kessler M, Lenington S, Sittek H, Reiser M (2000) Electrical impedance measurement of the breast: effect of hormonal changes associated with the menstrual cycle. Eur Radiol 10:1550-1554
29. Piperno G, Frei E, Moshitzky M (1990) Breast cancer screening by impedance measurements. Front Med Biol Eng 2:111-117
30. Rizzatto G (2001) Towards a more sophisticated use of breast ultrasound. Eur Radiol 11:2425-2435
31. Robinson MK, Doss M, Shaller C et al. (2005) Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody. Cancer Res 65:1471-1478
32. Rotten D, Levaillant J-M, Zerat L (1999) Analysis of normal breast tissue and of solid breast masses using three-dimensional ultrasound mammography. Ultrasound Obstet Gynecol 14:114-124
33. Smyczek-Gargya B, Fersis N, Dittmann H et al. (2004) PET with [18F]fluorothymidine for imaging of primary breast cancer: A pilot study. Eur J Nucl Med Mol Imaging 31:720-724
34. Stojadinovic A, Nissan A, Gallimidi Z, Lenington S, Logan W, Zuley M, Yeshaya A, Shimonov M, Melloul M, Fields S, Allweis T, Ginor R, Gur D, Shriver CD (2005) Electrical impedance scanning for the early detection of breast cancer in young women: preliminary results of a multicenter prospective clinical trial. J Clin Oncol 23:2703-2715
35. Surowiec AJ, Stuchly SS, Barr JR et al. (1988) Dielectric properties of breast carcinoma and the surrounding tissues. IEEE Trans Biomed Eng 35:257-263
36. Tung CH (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 60 Sept 1, 4953-4958
37. Weismann CF (2000) Breast ultrasound: new frontiers in imaging? Ultrasound Obstet Gynecol 15:279-281
38. Weismann CF (2005) Recent advances in multidimensional 3D/4D breast imaging. In: Ueno E, Shiina T, Kubota M, Sawai K (eds) Research and development in breast ultrasound. Springer, Tokyo, pp 146-150
39. Woodhams R (2005) ADC mappring of benign and malignant breast tumors. Magn Reson Med Sci 4(1):35-42
40. Yagle KJ, Eary JF, Tait JF et al. (2005) Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J Nucl Med 46:658-666
41. Zou Y, Guo Z (2003) A review of electrical impedance techniques for breast cancer detection. Med Eng Physiol 25:79-90